Fight Cat Allergies With Newest Asthma Drug?
3 minute readPublished: Thursday, October 13, 2022 at 9:48 pm

While the randomized CATNIP trial failed to meet its primary endpoint -- a difference in total nasal symptom score (TNSS) when participants were exposed to cat allergen extract a year after stopping treatment -- a reduction in peak nasal symptoms was observed when tezepelumab was added to SCIT,